About
Nanotechnology-enabled platform for diagnostics
Areas of Focus
Categories
NanotechDiagnosticsSoutheastern U.S.
Clinical Trials (23)
View allTotal Trials
23
As Lead Sponsor
8
As Collaborator
15
Total Enrollment
4,608
By Phase
PHASE1/PHASE2: 1PHASE2: 6PHASE1: 1NA: 6PHASE3: 1EARLY_PHASE1: 1
By Status
COMPLETED: 16ACTIVE_NOT_RECRUITING: 3NOT_YET_RECRUITING: 1RECRUITING: 1UNKNOWN: 1TERMINATED: 1
Clinical Trials Pipeline23 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06218849Collaborator
Hybrid Interactive Avatars for Post-COVID Sufferers
N/ANot yet recruiting
130 participants
Started: Jan 31, 2024 · Completed: Dec 31, 2025
NCT05920798Collaborator
Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
PHASE1/PHASE2Recruiting
40 participants
Started: Sep 28, 2023 · Completed: Jul 15, 2027
NCT05981495Lead Sponsor
Clinical Evaluation of the NanoDetect-TB Mycobacterium Tuberculosis Detection Kit for the Diagnosis of Tuberculosis Disease
N/AUnknown
460 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2024
NCT03988036Collaborator
A Study With Pembrolizumab in Combination With Dual Anti-HER2 Blockade With Trastuzumab and Pertuzumab in Early Breast Cancer Patients With Molecular HER2-enriched Intrinsic Subtype (Keyriched-1)
PHASE2Completed
46 participants
Started: Aug 18, 2020 · Completed: May 31, 2022
NCT04393168Collaborator
Proof-of-concept Study of LymphMonitor 1.0 to Assess the Lymphatic Vessel Function
PHASE1Completed
10 participants
Started: May 22, 2020 · Completed: Jun 26, 2020
Locations (1)
Headquarters
New Orleans, LA, United States
Map
Loading map...